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Introduction 
     Oral bacteria are major etiologic agents of oral infectious diseases. Bacterial species 
can form oral biofilms by initial attachment to the tooth surface, followed by 
coaggregation and coadhesion. Previous studies have demonstrated associations 
between the presence of oral biofilms and oral infectious diseases, such as dental 
caries and periodontitis. Chlorhexidine (CHX) is one of the standard antibiofilm agents 
in the field of dentistry. However, the use of CHX has adverse effects, including staining 
of teeth, detrimental effects on oral cells, and development of hypersensitivity reactions. 
Therefore, development of novel agents for inhibiting the growth and ability of biofilm 
formation of bacteria is required as one of the strategies for the prevention of oral 
infectious diseases.     
     The use of plant extracts as alternative medical treatments has become popular  in 
recent years. The term “plant products” usually refers to secondary metabolites 
produced by plants. These subtances serve as the defense mechanism for the plant 
against predation by microorganisms, insects, and herbivores. Hibiscus sabdariffa L.  
(family Malvaceae), commonly known as roselle or red sorrel in English, is widely grown 
in Central and West Africa, Southeast Asia, and in other regions. Roselle is an annual, 
erect, bushy, 2-4 m tall herbaceous subshrub. The thick, red and fleshy, cup-shaped 
part of the flower is known as calyx; the calyx has been used worldwide in cold and hot 
beverages, puddings, and jellies.  
     The roselle calyx is rich in secondary metabolites, which have medicinal properties. 
Previous studies have shown that the calyx contain flavonoids, such as gossypetine, 
hibiscetin, and sabdaretin and has been used in folk medicine. The extract has 
antihypertensive, hepatoprotective, antihyperlipidemic, antioxidant, anticancer, anti-
inflamatory, and antimicrobial properties. Although some studies reported the effects of 
roselle as an herbal medicine, to date, only a few studies examined the effects of roselle 
calyx extract (RCE) as an antibacterial agent, particularly in the field of dentistry. Thus, 
the purpose of this study was to investigate the potential activities of RCE against oral 
bacteria, in particular, the antibacterial activity against, cytotoxicity and effect on biofilm 
formation, gingipain activity, cytokines production, and morphology of oral bacteria. 
Materials and Methods  
      Roselle calyx powder was soaked in ethyl alcohol for 24 h at room temperature. 
After centrifugation, the extract was lyophilized and dissolved in phosphate-buffered 
saline (PBS). The pH was adjusted, and the extract was aseptically filtered. The 
bacteria used in this study were Streptococcus mutans, Streptococcus sanguinis, 
Lactobacillus casei, Actinomyces naeslundii, Aggregatibacter actinomycetemcomitans, 
Fusobacterium nucleatum, Porphyromonas gingivalis, and Prevotela intermedia. The 
antibacterial activity of the RCE was determined by treating the bacterial cells with the 
extract for 10–20 min at room temperature. The minimum inhibitory concentration (MIC) 
and minimum bactericidal concentration (MBC) were determined using the micro-
dilution method, and the effect of the RCE on biofilm formation was determined using a 
polystyrene micro plate assay. In addition, we used the WST-1 assay to determine the 
cytotoxicity of the RCE on HGF, Ca 9-22, and KB cells. The effect of RCE on Kgp and 
Rgp was evaluated using a synthetic substrate colorimetric assay. Additionally, its effect 
on cytokine production was quantified using ELISA kit and the morphological alterations 
in the cells of Streptococcus mutans and Porphyromonas gingivalis were studied using 
scanning electron microscopy (SEM). 
Results  
     The number of viable bacteria in the RCE-treated group was significantly lower than 
that in the control group were. In particular, significant antibacterial activity was 
observed against F. nucleatum, P. intermedia, and P. gingivalis. The MIC ranged from 
7.2 to 28.8 mg/mL, while the MBC ranged from 14.4 to > 57.6 mg/mL. RCE at the sub-
MIC level inhibited biofilm formation by all eight bacterial species in a dose-dependent 
manner. RCE showed less cytotoxicity to human oral cells and inhibited Kgp and Rgp 
activities. In addition, it inhibited the production of IL-6 and IL-8 from KB cells induced 
by P. gingivalis in a dose-dependent manner. After treatment with RCE, some part of S. 
mutans showed irregular shape such as enlargement and clumping of cells. In P. 
gingivalis, treatment with RCE caused aggregation and distortion of cellular morphology. 
Discussion 
     We found that RCE had bactericidal activity against both cariogenic and 
periodontopathic bacteria. RCE showed the strongest inhibitory activity against F. 
nucleatum, P. intermedia, and P. gingivalis, which indicated that RCE was more 
effective against gram-negative bacteria than gram-positive bacteria. The antibacterial 
activity observed in our study may be because of the main compound in RCE, such as 
flavonoids, which have the ability to bind to bacterial cell walls, disrupts the membrane 
integrity, resulting in death. In addition, our results showed that RCE at sub-MIC levels 
could inhibit the formation of biofilm by eight bacteria in a dose-dependent manner. The 
inhibitory effects of the extract on biofilm formation may be depend on the phenolic 
compounds present in the extract, because these compounds bind strongly to proteins 
and the enzymes, thus bacteria are unable to attach to the tooth surface.   
     When considering the development of  novel agents as oral care products, their toxic 
effects on human oral mucosal cells should be carefully examined. An ideal oral care 
product should be an efficient antimicrobial agent but should not be toxic to human oral 
cells. Results from our study indicated that RCE is safe to be used as an oral care 
product.  
     Our study reported that RCE inhibited the activity of Kgp and Rgp at a sub-MIC 
concentration. This activity may be due to polyphenol compounds as reported in 
previous study. Moreover, the RCE showed an inhibitory effect on IL-6 and IL-8. The 
mechanism of inhibition may be via a down-regulation of the activator protein-1 activity 
(AP-1). From the SEM observations, there was distortion of cellular morphology of S. 
mutans and P. gingivalis that would result in bacterial death, after treatment with RCE.      
Conclusion 
     Because of the favorable bioactivity and the simple process involved in producing  
the extract from the plant, the RCE has a high potential to be used as a novel agent for 
preventing oral infectious diseases. 
 
